Cancer Research Meeting Calendar  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Izawa, M.
Right arrow Articles by Kannagi, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Izawa, M.
Right arrow Articles by Kannagi, R.
[Cancer Research 60, 1410-1416, March 1, 2000]
© 2000 American Association for Cancer Research


Tumor Biology

Expression of Sialyl 6-Sulfo Lewis X Is Inversely Correlated with Conventional Sialyl Lewis X Expression in Human Colorectal Cancer1

Mineko Izawa, Kensuke Kumamoto, Chikako Mitsuoka, Akiko Kanamori, Katsuyuki Ohmori, Hiroji Ishida, Shigeo Nakamura, Kazumi Kurata-Miura, Katsutoshi Sasaki, Tatsunari Nishi and Reiji Kannagi2

Program of Experimental Pathology [M. I., K. K., C. M., A. K., R. K.] and Laboratory for Clinical Pathology [H. I., S. N.], Aichi Cancer Center, Nagoya, 464-8681; Central Clinical Laboratory, Kyoto University Hospital, Sakyoku, Kyoto 606-8501 [K. O.]; and Tokyo Research Laboratories, Kyowa Hakko Kogyo Co., Ltd., Tokyo 194-8533 [K. K-M., K. S., T. N.], Japan

Sialyl 6-sulfo Lewis X determinant has been described recently as a major ligand for L-selectin on high endothelial venules of human peripheral lymph nodes. From our investigation of its distribution in human colorectal cancer tissues and cultured colon cancer cells, the sialyl 6-sulfo Lewis X determinant was preferentially expressed in the nonmalignant colonic epithelia rather than cancer cells (P < 0.001; n = 23). This was in contrast to the distribution of conventional sialyl Lewis X, which was preferentially expressed in cancer tissues rather than nonmalignant epithelia (P = 0.007; n = 23), indicating that 6-sulfation predominantly occurs in nonmalignant tissues and is suppressed upon malignant transformation. In confirmation of this, a nonsialylated determinant 6-sulfo Lewis X was also found to be preferentially localized in the nonmalignant epithelia. Significant expression of sialyl 6-sulfo Lewis X was observed in only 2 lines, whereas 8 were positive for conventional sialyl Lewis X, among 13 cultured colon cancer cell lines. Transfection of cells with fucosyltransferase (Fuc-T) VI induced expression of sialyl 6-sulfo Lewis X, whereas transfection of Fuc-T III did not, suggesting that the determinant was synthesized mainly by Fuc-T VI in colonic epithelia. Members of the sialic acid cyclase pathway, the de-N-acetyl sialyl 6-sulfo Lewis X and cyclic sialyl 6-sulfo Lewis X determinants, were also preferentially expressed in the nonmalignant epithelia rather than colonic cancer cells (P < 0.001; n = 23). Stimulation of the sialyl 6-sulfo Lewis X-positive colon cancer cell line with a calcium ionophore ionomycin markedly reduced sialyl 6-sulfo Lewis X and induced cyclic sialyl 6-sulfo Lewis X expression. These results suggested that the metabolic conversion of sialyl 6-sulfo Lewis X into cyclic sialyl 6-sulfo Lewis X by a calcium-dependent enzyme, sialic acid cyclase, as we hypothesized for human leukocytes previously (C. Mitsuoka et al., Proc. Natl. Acad. Sci. USA, 96: 1597–1602, 1999), also occurs in nonmalignant colonic epithelia.




This article has been cited by other articles:


Home page
Clin. Chem.Home page
Z. Kyselova, Y. Mechref, P. Kang, J. A. Goetz, L. E. Dobrolecki, G. W. Sledge, L. Schnaper, R. J. Hickey, L. H. Malkas, and M. V. Novotny
Breast Cancer Diagnosis and Prognosis through Quantitative Measurements of Serum Glycan Profiles
Clin. Chem., July 1, 2008; 54(7): 1166 - 1175.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Kamiyama, N. Sasaki, E. Goda, K. Ui-Tei, K. Saigo, H. Narimatsu, Y. Jigami, R. Kannagi, T. Irimura, and S. Nishihara
Molecular Cloning and Characterization of a Novel 3'-Phosphoadenosine 5'-Phosphosulfate Transporter, PAPST2
J. Biol. Chem., April 21, 2006; 281(16): 10945 - 10953.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Ohmori, F. Fukui, M. Kiso, T. Imai, O. Yoshie, H. Hasegawa, K. Matsushima, and R. Kannagi
Identification of cutaneous lymphocyte-associated antigen as sialyl 6-sulfo Lewis X, a selectin ligand expressed on a subset of skin-homing helper memory T cells
Blood, April 15, 2006; 107(8): 3197 - 3204.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
S. L. Tjew, K. L. Brown, R. Kannagi, and P. Johnson
Expression of N-acetylglucosamine 6-O-sulfotransferases (GlcNAc6STs)-1 and -4 in human monocytes: GlcNAc6ST-1 is implicated in the generation of the 6-sulfo N-acetyllactosamine/Lewis x epitope on CD44 and is induced by TNF-{alpha}
Glycobiology, July 1, 2005; 15(7): 7C - 13C.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Uchimura, K. Kadomatsu, F. M. El-Fasakhany, M. S. Singer, M. Izawa, R. Kannagi, N. Takeda, S. D. Rosen, and T. Muramatsu
N-Acetylglucosamine 6-O-Sulfotransferase-1 Regulates Expression of L-Selectin Ligands and Lymphocyte Homing
J. Biol. Chem., August 13, 2004; 279(33): 35001 - 35008.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Miyazaki, K. Ohmori, M. Izawa, T. Koike, K. Kumamoto, K. Furukawa, T. Ando, M. Kiso, T. Yamaji, Y. Hashimoto, et al.
Loss of Disialyl Lewisa, the Ligand for Lymphocyte Inhibitory Receptor Sialic Acid-Binding Immunoglobulin-Like Lectin-7 (Siglec-7) Associated with Increased Sialyl Lewisa Expression on Human Colon Cancers
Cancer Res., July 1, 2004; 64(13): 4498 - 4505.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Seko, N. Dohmae, K. Takio, and K. Yamashita
beta 1,4-Galactosyltransferase (beta 4GalT)-IV Is Specific for GlcNAc 6-O-Sulfate. beta 4GalT-IV ACTS ON KERATAN SULFATE-RELATED GLYCANS AND A PRECURSOR GLYCAN OF 6-SULFOSIALYL-LEWIS X
J. Biol. Chem., March 7, 2003; 278(11): 9150 - 9158.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Tei, N. Kawakami-Kimura, O. Taguchi, K. Kumamoto, S. Higashiyama, N. Taniguchi, K.'i. Toda, R. Kawata, Y. Hisa, and R. Kannagi
Roles of Cell Adhesion Molecules in Tumor Angiogenesis Induced by Cotransplantation of Cancer and Endothelial Cells to Nude Rats
Cancer Res., November 1, 2002; 62(21): 6289 - 6296.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
M. Delcommenne, R. Kannagi, and P. Johnson
TNF-{alpha} increases the carbohydrate sulfation of CD44: induction of 6-sulfo N-acetyl lactosamine on N- and O-linked glycans
Glycobiology, October 1, 2002; 12(10): 613 - 622.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Ikeda, H. Eguchi, S. Nishihara, H. Narimatsu, R. Kannagi, T. Irimura, M. Ohta, H. Matsuda, N. Taniguchi, and K. Honke
A Remodeling System of the 3'-Sulfo-Lewis a and 3'-Sulfo-Lewis x Epitopes
J. Biol. Chem., October 12, 2001; 276(42): 38588 - 38594.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.